Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BOSULIF 100 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BOSULIF 100 MG CAPSULAS DURAS

Approved

STANDARD

BOSULIF 100 MG CAPSULAS DURAS

Pfizer Europe Ma Eeig🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 23, 2025
Approval ID: b270fdb07b932c44
Company: Pfizer Europe Ma Eeig
Type: Standard

Approval Details

Approval Id: b270fdb07b932c44
Drug Cima Aemps Name: BOSULIF 100 MG CAPSULAS DURAS
Register Number: 113818009
Holder Company Name: Pfizer Europe Ma Eeig
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/ca5e34506d2325ab/pfizer-europe-ma-eeig
Authorization Date: 2025-06-23
Dosage Form: CÁPSULA DURA
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Pfizer Europe Ma Eeig
Company Detail Path: /organization/ca5e34506d2325ab/pfizer-europe-ma-eeig

Company Information

Pharmaceutical Company Name: Pfizer Europe MA EEIG
Country Name: United Kingdom

Active Ingredients

BOSUTINIB MONOHIDRATO

103,40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 23, 2025

Approval ID

b270fdb07b932c44

Type

Standard

Back to CIMA-AEMPS Approvals